Novavax earnings expectations
WebFeb 10, 2024 · NVAX’s surprise record has been dismal so far, as its earnings missed expectations in each of the last four quarters. It has a trailing four-quarter negative earnings surprise of 280.19%, on... WebApr 15, 2024 · The consensus estimate for Novavax’s current full-year earnings is ($5.66) per share. ... The company had revenue of $357.40 million during the quarter, compared …
Novavax earnings expectations
Did you know?
WebApr 9, 2024 · Novavax, Inc. has a 12 month low of $5.61 and a 12 month high of $76.77. Novavax (NASDAQ:NVAX – Get Rating) last announced its earnings results on Tuesday, February 28th. The biopharmaceutical ... WebMay 10, 2024 · The company reiterated its expectation for $4 billion to $5 billion in full-year revenue. The midpoint of the outlook is in line with NVAX stock analyst estimates for $4.49 billion. Analysts also...
WebNov 1, 2024 · Nov 1, 2024 01:26PM EDT Novavax, Inc. NVAX is scheduled to report third-quarter 2024 results on Nov 4, after market close. The company’s surprise record has been dismal so far as its earnings... WebApr 15, 2024 · Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earn $1.95 per share for the year, up from their previous estimate of $1.87. …
WebApr 13, 2024 · NVAX Novavax, Inc. Earnings Estimates $ +11.46% NASDAQ $USD Post-Market: $8.49 +0.03 (+0.35%) 7:59 PM Earnings Dividends Valuation Growth Profitability … WebFeb 23, 2024 · Novavax, Inc. NVAX is scheduled to report fourth-quarter 2024 results on Feb 28, after market close. The company’s surprise record has been dismal so far, as its …
WebFeb 23, 2024 · Novavax, Inc. NVAX is scheduled to report fourth-quarter 2024 results on Feb 28, after market close. The company’s surprise record has been dismal so far, as its earnings missed expectations in ...
WebSep 24, 2024 · Following the downgrade, the current consensus from Novavax's six analysts is for revenues of US$2.0b in 2024 which - if met - would reflect a huge 58% increase on its sales over the past 12... first source credit card perksWebApr 15, 2024 · Zacks Research analyst S. Ganoria now forecasts that the biopharmaceutical company will earn $1.95 per share for the year, up from their previous estimate of $1.87. The consensus estimate for Novavax's current full-year earnings is ($5.66) per share. A number of other equities research analysts have also recently commented on the stock. first source building materialsWebOct 25, 2024 · Novavax saw profits in Q1, when it reported $700 million in revenues and $200 million in earnings. It's still early days, and the company doesn't give quarterly estimates or earnings... camp arrowhead campWebJul 28, 2024 · NVAX’s surprise record has been dismal so far, as its earnings missed expectations in each of the last four quarters. It has a trailing four-quarter negative earnings surprise of 184.49%, on... camp arrowhead miltonWebMay 10, 2024 · The company reiterated its expectation for $4 billion to $5 billion in full-year revenue. The midpoint of the outlook is in line with NVAX stock analyst estimates for … camp arrowhead hunt texasWebApr 11, 2024 · The trading price of Novavax Inc. (NASDAQ:NVAX) closed lower on Monday, April 10, closing at $8.00, -5.44% lower than its previous close. ... Inc., whose market valuation is $618.56 million at the time of this writing, is expected to release its quarterly earnings report May 08, 2024 – May 12, 2024. Investors’ optimism about the company’s ... camp arrowhead mnWebFeb 28, 2024 · In the three months that ended December, the Gaithersburg, MD.-based company is expected to post a per-share loss of 92 cents on revenue of $383.14 million. This compares to the year-ago quarter... first source company in bangalore